According to Xilio Therapeutics's latest financial reports the company's current earnings (TTM) are -NZ$0.12 B. In 2022 the company made an earning of -NZ$0.15 B a decrease over its 2021 earnings that were of -NZ$0.13 B.The earnings displayed on this page is the company's Pretax Income.